PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

31 hedge funds and large institutions have $1.38M invested in Protalix BioTherapeutics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
3
Calls
$20K
Puts
$50K
Net Calls
-$30K
Net Calls Change
+$66K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$913K
2
WS
2
Wedbush Securities
California
$30K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$6K
4
Victory Capital Management
4
Victory Capital Management
Texas
$5K
5
Group One Trading
5
Group One Trading
Illinois
$47K

Top Sellers

1
FI
1
Fosun International
China
$0
2
OM
2
Opaleye Management
Massachusetts
$0
3
JGC
3
J. Goldman & Co
New York
$25K
4
UBS Group
4
UBS Group
Switzerland
$14K
5
MIH
5
Meitav Investment House
Israel
$13K
Name Holding Trade Value Shares
Change 		Shares
Change %
AA
26
Advisory Alpha
Michigan
$950 +$950 +500 New
FI
27
Fosun International
China
– -$1.24M -263,140 Closed
OM
28
Opaleye Management
Massachusetts
– -$469K -100,000 Closed
VF
29
Virtu Financial
New York
– -$9K -1,948 Closed
1
2